What Is Svt Ablation And How Does The Procedure Work?

Supraventricular tachycardia, or SVT, is a group of heart rhythm problems that start in the upper chambers of the heart and cause a sudden racing heartbeat. When medications fail to control these episodes or cause troublesome side effects, doctors may recommend a procedure called SVT ablation. This procedure uses a thin, flexible tube called a catheter to deliver energy to a tiny area of heart tissue that is generating the abnormal rhythm. The goal is to destroy that small patch of tissue so the faulty electrical signal can no longer trigger the rapid heartbeat.

What Is SVT Ablation and How Does the Procedure Work?

SVT ablation is a minimally invasive cardiac procedure that targets the specific tissue causing an abnormal fast heart rhythm. It is a type of catheter ablation, meaning the entire procedure is performed through blood vessels, usually in the groin, without opening the chest.

The heart has its own electrical system that controls how fast and how regularly it beats. In SVT, an extra electrical pathway or an irritable cluster of cells disrupts that system. These disruptions create a short circuit that makes the heart race, often suddenly and without warning.

During the procedure, a doctor inserts a catheter into a blood vessel and threads it up to the heart. Specialized electrodes on the catheter record electrical signals from inside the heart. This mapping process helps the doctor find the exact spot causing the problem. Once located, the catheter delivers energy — most commonly radiofrequency energy, which heats tissue, or cryoenergy, which freezes it — to create a small scar. That scar blocks the abnormal electrical signal.

The procedure typically takes one to three hours, depending on the type of SVT and how difficult the target area is to reach. Most patients receive sedation or general anesthesia, so they feel little to nothing during the procedure.

What Types of SVT Can Be Treated With Ablation?

Ablation works best for SVTs caused by a discrete, identifiable electrical pathway or focus. The most common types treated with this approach include:

• AV nodal reentrant tachycardia (AVNRT): The most common form of SVT. It involves an extra pathway near the AV node, the electrical gateway between the upper and lower chambers.
• AV reentrant tachycardia (AVRT): Caused by an extra pathway connecting the atria and ventricles, sometimes visible on a resting ECG as a “delta wave” (Wolff-Parkinson-White syndrome).
• Atrial tachycardia: A rapid rhythm originating from a specific spot in the upper chambers.
• Atrial flutter: A related rhythm that can also be treated with ablation, though it is sometimes classified separately from SVT.

Not every fast heartbeat is an SVT. Atrial fibrillation, for example, is a different rhythm disorder that requires a different treatment approach. A doctor confirms the specific diagnosis through ECG recordings, Holter monitoring, or event monitors before recommending ablation.

Who Is a Candidate for SVT Ablation?

Ablation is generally considered when SVT episodes are frequent, bothersome, or hard to control with medication. Some people choose ablation as a first treatment rather than trying medications for years. Others try medication first and turn to ablation if drugs do not work well or cause side effects.

Doctors also consider ablation when SVT causes fainting, chest discomfort, or significant disruption to daily life. In some cases — particularly with Wolff-Parkinson-White syndrome — ablation may be recommended because the extra pathway carries a small but real risk of a dangerous rhythm if it conducts rapidly to the ventricles.

The decision is not automatic. Some SVT episodes are mild and infrequent enough that a person and their doctor decide the risks of a procedure are not worth it. Catheter ablation, while generally safe, is not risk-free.

What Happens During and After the Procedure?

Before the procedure, patients usually fast for several hours. A doctor inserts an IV for medications and fluids. In most cases, the catheter is placed through a blood vessel in the groin, though the neck or arm may also be used.

Once the catheters are in place, the doctor uses them to map the heart’s electrical activity and to trigger the SVT intentionally. This step confirms the diagnosis and pinpoints the target. After delivering energy to the target area, the doctor tests again to see whether the abnormal rhythm can still be triggered.

If the SVT no longer occurs, the procedure is considered successful. The catheters are removed, and pressure is applied to the insertion site to prevent bleeding.

Most patients go home the same day or the next morning. Doctors typically advise avoiding strenuous activity and heavy lifting for a short period — often about a week — to let the insertion site heal. Mild bruising or soreness at the site is common. Some people feel occasional skipped beats or brief palpitations in the days after the procedure; these often settle on their own, but any new or worsening symptoms should be reported to a doctor.

What Are the Risks and Success Rates?

Catheter ablation for SVT is generally considered a low-risk procedure, but it is not without risk. The most common complications are minor and related to the catheter insertion site, such as bleeding or bruising. More serious but uncommon risks include:

• Damage to the heart’s normal electrical system, which in rare cases could require a pacemaker
• Blood clots that could travel to the lungs or brain
• Fluid buildup around the heart
• Damage to blood vessels or heart valves
• Radiation exposure from the X-ray imaging used during the procedure

Success rates vary by the type of SVT. For AVNRT and AVRT, ablation is highly effective, with most patients free of the arrhythmia afterward. For other types, success rates are somewhat lower, and a second procedure may be needed.

It is important to understand that “success” means the targeted rhythm no longer occurs. It does not guarantee that a person will never develop a different heart rhythm problem in the future. Some people still experience occasional palpitations after a successful ablation, though these are usually harmless and not the original SVT.

Complication rates for SVT ablation are low, but they are not zero. A person considering the procedure should discuss their individual risk with their cardiologist, including factors like age, other health conditions, and the specific type of SVT.

How Does Ablation Compare With Medication?

Medications for SVT — such as beta-blockers or calcium channel blockers — can reduce how often episodes happen and how fast the heart beats during an episode. But they do not cure the underlying electrical problem. Many people still have breakthrough episodes, and some cannot tolerate the side effects, which can include fatigue, low blood pressure, or dizziness.

Ablation offers the possibility of a permanent fix for certain types of SVT. For AVNRT, for example, successful ablation eliminates the arrhythmia in the vast majority of patients, often without the need for ongoing medication.

That said, ablation is a procedure with real risks, while medication is reversible. Some people prefer to try medication first. Others, especially those with frequent or severe episodes, choose ablation early. There is no single right answer — it depends on the person’s symptoms, preferences, and medical history.

One point that is sometimes overlooked: even after successful ablation, some patients remain on a beta-blocker for a period of time. This is not because the ablation failed, but because the heart can be irritable in the weeks after the procedure, and medication helps keep things calm while the tissue heals.

What Should You Expect in the Long Term?

For most people who have a successful SVT ablation, the long-term outlook is good. The arrhythmia does not return in the majority of cases, and many people are able to stop taking rhythm-controlling medications entirely.

Follow-up usually involves a visit with a cardiologist a few weeks to a few months after the procedure. Some patients wear a monitor for a short time to confirm the rhythm is normal. If symptoms return, further testing can determine whether the original problem came back or whether something new is going on.

It is also worth knowing that SVT itself is rarely life-threatening in people with a structurally normal heart. The main reasons to treat it are symptoms and quality of life. That context matters when weighing whether ablation is worth it — the goal is usually to feel better, not to prevent a heart attack or sudden death, except in specific situations like Wolff-Parkinson-White syndrome with high-risk features.